About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

New Drug to Fight Alzheimer's Disease Soon from AstraZeneca, Eli Lilly Combo

by Thilaka Ravi on September 17, 2014 at 12:14 PM
Font : A-A+

New Drug to Fight Alzheimer's Disease Soon from AstraZeneca, Eli Lilly Combo

British drugmaker AstraZeneca and Eli Lilly of the United States announced a partnership on Tuesday to develop a new drug aimed at treating Alzheimer's disease, the most common form of dementia.

Alzheimer's disease is a neurodegenerative disorder in which a buildup of amyloid plaque in the brain destroys neurons. The disease is rapidly growing and poses the biggest challenge in medical science.

Advertisement

Only a handful of drugs are available to treat the symptoms of Alzheimer's that can include memory loss, confusion, irritability, aggression and mood swings.

The idea behind the prototype drug is to disrupt the build up of neuron-destroying plaque.

The drug's designers hope that an "inhibitor" targeting an enzyme called BACE that plays a key part in the buildup of plaque will slow progression of the disease.
Advertisement

"AstraZeneca and Eli Lilly ... today announced an agreement to jointly develop and commercialise AZD3293, an oral beta secretase cleaving enzyme (BACE) inhibitor currently in development as a potential treatment for Alzheimer's disease," the companies said in a statement.

Under the deal, Lilly will pay AstraZeneca up to $500 million (386 million euros) if the drug reaches key development and regulatory milestones.

AstraZeneca added that AZD3293 has been shown in Phase 1 studies -- the first in the lengthy three-step process to vet a new drug for safety and effectiveness -- to significantly reduce levels of amyloid beta in the cerebro-spinal fluid of Alzheimer's patients and healthy counterparts.

"Alzheimer's disease is one of the biggest challenges facing medical science today and BACE inhibitors have the potential to target one of the key drivers of disease progression," said Mene Pangalos, AstraZeneca's executive vice president of innovative medicines and early development, in the statement.

Health systems in Western countries are struggling to deal with Alzheimer's as it is costly to treat sufferers of the incurable disease which leaves sufferers increasingly reliant on assistance.

Source: AFP
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
January is the Thyroid Awareness Month in 2022
Menstrual Disorders
Coffee May Help You Fight Endometrial Cancer
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Alzheimers Disease Drug Toxicity Clinical Trials - Different Phases of the trial Signature Drug Toxicity Diet and Alzheimer´s Disease Genetics of Alzheimer´s disease 

Recommended Reading
Alzheimers Disease
Alzheimer's disease is a progressive neurodegenerative disease affecting memory and thinking and ......
Alzheimer’s Disease Day: Treating Dementia with Care Rather Than Cure
Alzheimer's disease has no cure and patients need care more than cure, says Ravi Samuel, Cognitive ....
Caring for Alzheimers disease patients
Alzheimer's disease is a complex brain disorder that triggers the most common form of dementia. The ...
Diseases Related to Old Age
Ageing is referred to the accumulation of changes that brings a person closer to death....
Clinical Trials - Different Phases of the trial
Clinical trials serve as a vital component for improving the treatment of medical conditions as they...
Diet and Alzheimer´s Disease
Alzheimer''s begins with forgetfulness, but over time affects speech and coordination along with dra...
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Genetics of Alzheimer´s disease
There are numerous genes that have been discovered that are associated with Alzheimer’s disease and ...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
ASK A DOCTOR ONLINE
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)